Xosé Pérez-Fernández

1.8k total citations
18 papers, 193 citations indexed

About

Xosé Pérez-Fernández is a scholar working on Nephrology, Epidemiology and Pharmacology. According to data from OpenAlex, Xosé Pérez-Fernández has authored 18 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 7 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Xosé Pérez-Fernández's work include Acute Kidney Injury Research (6 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Xosé Pérez-Fernández is often cited by papers focused on Acute Kidney Injury Research (6 papers), Pneumonia and Respiratory Infections (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Xosé Pérez-Fernández collaborates with scholars based in Spain, France and United States. Xosé Pérez-Fernández's co-authors include Joan Sabater‐Riera, Raül Rigo‐Bonnin, Antoni Betbesé, Pedro Alía, Ariadna Padullés, Fé Tubau, R. Granada, Alba Ribera, Evelyn Shaw and Óscar Murillo and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, International Journal of Environmental Research and Public Health and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Xosé Pérez-Fernández

15 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xosé Pérez-Fernández Spain 7 90 70 42 35 33 18 193
Matthias Gijsen Belgium 11 218 2.4× 115 1.6× 59 1.4× 26 0.7× 20 0.6× 32 307
Ilse M. Purmer Netherlands 7 98 1.1× 97 1.4× 36 0.9× 106 3.0× 33 1.0× 12 282
Kunihiro Shirai Japan 10 113 1.3× 84 1.2× 39 0.9× 15 0.4× 107 3.2× 27 307
Evelyn Dhont Belgium 9 231 2.6× 124 1.8× 42 1.0× 64 1.8× 28 0.8× 30 340
Anka C. Röhr Germany 10 205 2.3× 121 1.7× 72 1.7× 21 0.6× 19 0.6× 22 280
Juri Karjagin Estonia 8 94 1.0× 48 0.7× 32 0.8× 15 0.4× 98 3.0× 17 261
Emmanuel Novy France 9 109 1.2× 142 2.0× 24 0.6× 48 1.4× 81 2.5× 33 377
Nicole R. Zane United States 12 111 1.2× 79 1.1× 17 0.4× 20 0.6× 19 0.6× 21 364
Sahand Imani Australia 6 246 2.7× 158 2.3× 71 1.7× 21 0.6× 35 1.1× 11 308
Yue‐E Wu China 10 155 1.7× 90 1.3× 33 0.8× 10 0.3× 30 0.9× 46 315

Countries citing papers authored by Xosé Pérez-Fernández

Since Specialization
Citations

This map shows the geographic impact of Xosé Pérez-Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xosé Pérez-Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xosé Pérez-Fernández more than expected).

Fields of papers citing papers by Xosé Pérez-Fernández

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xosé Pérez-Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xosé Pérez-Fernández. The network helps show where Xosé Pérez-Fernández may publish in the future.

Co-authorship network of co-authors of Xosé Pérez-Fernández

This figure shows the co-authorship network connecting the top 25 collaborators of Xosé Pérez-Fernández. A scholar is included among the top collaborators of Xosé Pérez-Fernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xosé Pérez-Fernández. Xosé Pérez-Fernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Betbesé, Antoni, Josep J. Centelles, Daniel Iglesias‐Serret, et al.. (2025). Buffers in intravenous solutions: is the source of bicarbonate a source of confusion?. Critical Care. 29(1). 539–539.
2.
Ulsamer, Arnau, et al.. (2025). The pathogenesis of ventilator-associated pneumonia: old and new mechanisms. Expert Review of Respiratory Medicine. 19(7). 655–671. 1 indexed citations
3.
Sabater‐Riera, Joan, et al.. (2023). Days spent on non-invasive ventilation support: can it determine when to initiate VV- ECMO? Observational study in a cohort of Covid-19 patients. BMC Pulmonary Medicine. 23(1). 310–310. 2 indexed citations
4.
Colom, Helena, Evelyn Shaw, Joan Sabater‐Riera, et al.. (2023). Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients. Antibiotics. 12(3). 531–531. 3 indexed citations
5.
Gasa, Mercè, Yolanda Ruíz, Ana Córdoba-Izquierdo, et al.. (2022). Outcomes of COVID-19 Patients Admitted to the Intermediate Respiratory Care Unit: Non-Invasive Respiratory Therapy in a Sequential Protocol. International Journal of Environmental Research and Public Health. 19(17). 10772–10772. 1 indexed citations
6.
Chaïbi, Khalil, Melissa Dominicé Dao, Arthur Pavot, et al.. (2021). Severe Acute Kidney Injury in Patients with COVID-19 and Acute Respiratory Distress Syndrome (vol 202, pg 1299, 2020). American Journal of Respiratory and Critical Care Medicine. 203(1). 151–151.
7.
Rigo‐Bonnin, Raül, Xosé Pérez-Fernández, Luisa Corral, et al.. (2021). Individual outcome prediction models for patients with COVID-19 based on their first day of admission to the intensive care unit. Clinical Biochemistry. 100. 13–21. 5 indexed citations
8.
Shaw, Evelyn, Joan Sabater‐Riera, Xosé Pérez-Fernández, et al.. (2021). Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?. European Journal of Drug Metabolism and Pharmacokinetics. 46(4). 527–538. 4 indexed citations
9.
Chaïbi, Khalil, Tài Pham, Arthur Pavot, et al.. (2020). Severe Acute Kidney Injury in Patients with COVID-19 and Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 202(9). 1299–1301. 24 indexed citations
11.
Lopez‐Delgado, Juan Carlos, et al.. (2017). Factors Associated with the Development of Tertiary Peritonitis in Critically Ill Patients. Surgical Infections. 18(5). 588–595. 7 indexed citations
14.
Pérez-Fernández, Xosé, et al.. (2017). No impact of surviving sepsis campaign care bundles in reducing sepsis-associated acute kidney injury. Clinical Nephrology. 88(8). 105–111. 3 indexed citations
15.
Lopez‐Delgado, Juan Carlos, et al.. (2015). Surgical site infection in critically ill patients with secondary and tertiary peritonitis: epidemiology, microbiology and influence in outcomes. BMC Infectious Diseases. 15(1). 304–304. 30 indexed citations
16.
Sabater‐Riera, Joan, et al.. (2015). Timing of continuous renal replacement therapies in acute kidney injury patients after cardiac surgery. Intensive Care Medicine Experimental. 3(S1). 1 indexed citations
17.
Moreno‐González, Gabriel, et al.. (2015). Community acquired vs hospital acquired acute kidney injury. mortality and timing of renal replacement therapy. Intensive Care Medicine Experimental. 3(S1).
18.
Rigo‐Bonnin, Raül, E. Leiva Badosa, Joan Sabater‐Riera, et al.. (2014). Measurement of meropenem concentration in different human biological fluids by ultra-performance liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 406(20). 4997–5007. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026